Stada And Xbrane Win EU Endorsement For Ranibizumab

Ximluci, Third Biosimilar Rival To Lucentis, Receives Positive Opinion From CHMP

 
• By Dave Wallace
  
EU flag reflected in eye
Stada and Xbrane are eyeing the third European biosimilar ranibizumab approval • Source: Shutterstock

More from Biosimilars

More from Products